IP Library Granted Patent US 9,386,925
Granted Patent B2
US 9,386,925 · App. 12/299,809 · Granted Jul 12, 2016

Device for drug administration and/or monitoring the status of a patient

Inventors: Henrike Krijnsen (Boxtel, NL); Geert Langereis (Eindhoven, NL); Michel Van Bruggen (Helmond, NL); Ventzeslav Iordanov (Valkenswaard, NL)
Assignee: Medimetrics Personalized Drug Delivery B.V.
A61B5/0205A61B5/00A61B5/02055G06F19/3468A61B5/01A61B5/02A61B5/024
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,386,925
App. No.
12/299,809
Granted
Jul 12, 2016
Kind
B2
Abstract

The invention relates to a device for drug administration and/or monitoring the status of a patient, the device comprising a first and a second measuring means, and the time for using the second measuring means being set in accordance with the data of the first measuring means.

Claims (13)

1. A method for the controlled release of drugs and/or monitoring the status of a patient, the method comprising:

a) measuring at least one body parameter of the patient for at least three measuring cycles and at least one monitoring cycle,

b) generating a normalized curve for each of the measured body parameter(s) of the patient from the data obtained in the measuring cycles and adjusting the data obtained in the at least one monitoring cycle to normalized data based on the normalized curve to obtain normalized monitoring data,

c) starting and/or stopping a measurement of at least one second body parameter having a circadian variation in response to observed deviations of the normalized data on a normalized scale or observed deviations of the normalized monitoring data,

d) generating a fitting curve of data of the at least one second body parameter, and

e) starting a drug release by a drug release device based upon comparison of the data of step c) and/or d).

2. The method according to claim 1 , wherein the at least one first body parameter includes body temperature, core body temperature, skin surface temperature, body activity, brain activity, heart rate, melatonin level, triacylglycerol level, cortisol level.

3. The method according to claim 1 , wherein the at least one second body parameter is blood pressure.

4. The method according to claim 1 , wherein the second measuring means starts measuring when during the at least 1 monitoring cycle a change in the normalized monitoring data is observed of ≧40%/hour on a normalized scale over ≧1 hours.

5. The method according to claim 1 , wherein the second measuring means starts measuring when during the at least 1 monitoring cycle a drop in the normalized monitoring data is observed of ≧40%/hour on a normalized scale over ≧1 hours and/or the normalized data falls under an absolute value of 50%.

6. The method according to claim 1 , wherein the second measuring means is stopped when during the at least 1 monitoring cycle the normalized monitoring data deviates from the normalized 0%-point of the normalized curve by a threshold value of ≧5% and is increasing.

7. The method according to claim 1 , wherein the second measuring means is stopped when during the at least 1 monitoring cycle an average increase in the normalized monitoring data is observed of ≧40% hour on a normalized scale over hours and/or the normalized data rises above an absolute value of 40%.

8. The method according to claim 1 , wherein the comparison of the data of step c) and/or d) comprises the comparison of the data of step c) and/or d) with pre-stored comparison data.

Assignments (9)
SECURITY INTEREST Recorded Aug 15, 2025
From: BT BIDCO, INC.
To: GLAS USA LLC
Reel/Frame 072473/0861 →
LIEN Recorded Mar 31, 2025
From: BIORA THERAPEUTICS, INC.
To: BT BIDCO LLC
Reel/Frame 070690/0864 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2025
From: BIORA THERAPEUTICS, INC.
To: BT BIDCO, INC.
Reel/Frame 070688/0297 →
SECURITY INTEREST Recorded Dec 21, 2023
From: BIORA THERAPEUTICS, INC.
To: GLAS TRUST COMPANY LLC, AS COLLATERAL AGENT
Reel/Frame 066089/0235 →
CHANGE OF NAME Recorded Sep 19, 2023
From: PROGENITY, INC.
To: BIORA THERAPEUTICS, INC.
Reel/Frame 064961/0451 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2018
From: STOCO 10 GMBH
To: PROGENITY, INC.
Reel/Frame 045831/0981 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2017
From: MEDIMETRICS PERSONALIZED DRUG DELIVERY B.V.
To: STOCO 10 GMBH
Reel/Frame 043463/0820 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2012
From: KONINKLIJKE PHILIPS ELECTRONICS N.V.
To: MEDIMETRICS PERSONALIZED DRUG DELIVERY B.V.
Reel/Frame 027756/0865 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2008
From: KRIJNSEN, HENRIKE; LANGEREIS, GEERT; VAN BRUGGEN, MICHEL; IORDANOV, VENTZESLAV
To: KONINKLIJKE PHILIPS ELECTRONICS N V
Reel/Frame 021800/0832 →
Priority Claims (1)
EP 06113786 · May 11, 2006 · regional
Continuity (1)
Related Publication 20090099508A1 · Apr 16, 2009